BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6262169)

  • 1. Effect of islet-activating protein (IAP), purified from the culture medium of Bordetella pertussis, on the secretion of immunoreactive insulin and glucagon in normal, alloxan-treated, and depancreatized dogs.
    Yoshida T; Nakamura Y; Nakano K; Kondo M
    Diabetes; 1981 May; 30(5):430-4. PubMed ID: 6262169
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of islet-activating protein (IAP) upon insulin secretion from human pancreatic islets.
    Araki Y; Yoshida T; Nakamura N; Koyama K; Nakamura Y; Nakano K; Kondo M
    Endocrinol Jpn; 1981 Apr; 28(2):139-43. PubMed ID: 7030721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet-activating protein (IAP)-induced adrenergic modulation of pancreatic A and B cell in dogs.
    Nakamura N; Yoshida T; Nakamura Y; Araki Y; Nakano K; Kanatsuna T; Kondo M
    Horm Metab Res; 1984 Mar; 16(3):128-31. PubMed ID: 6370819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL; Kemmer FW; Doi K; Vranic M
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of islet-activating protein on cultured rat pancreatic islets. Enhancement of insulin secretion, adenosine 3':5'-monophosphate accumulation and 45Ca flux.
    Katada T; Ui M
    J Biochem; 1981 Apr; 89(4):979-90. PubMed ID: 6166608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Bordetella pertussis vaccine on glucagon secretion in normal and alloxan dogs.
    Nakamura Y; Yoshida T; Osumi T; Araki Y; Kondo M
    Endocrinol Jpn; 1980 Oct; 27(5):585-91. PubMed ID: 7016512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alloxan on insulin and glucagon secretion in perifused isolated islets.
    Tomita T
    Diabetologia; 1980 Aug; 19(2):154-7. PubMed ID: 6998818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation by alloxan of glucagon and insulin secretion in the isolated perfused rat pancreas.
    Goto Y; Seino Y; Taminato T; Inoue Y; Kadowaki S; Mori K; Imura H
    Endocrinology; 1978 May; 102(5):1496-500. PubMed ID: 369831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow interaction of islet-activating protein with pancreatic islets during primary culture to cause reversal of alpha-adrenergic inhibition of insulin secretion.
    Katada T; Ui M
    J Biol Chem; 1980 Oct; 255(20):9580-8. PubMed ID: 6253447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet-activating protein. Enhanced insulin secretion and cyclic AMP accumulation in pancreatic islets due to activation of native calcium ionophores.
    Katada T; Ui M
    J Biol Chem; 1979 Jan; 254(2):469-79. PubMed ID: 216676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan.
    Grill V; Efendić S
    Diabetologia; 1983 Jan; 24(1):47-51. PubMed ID: 6131006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced glucose-induced insulin release and endogenous Ca2+ ionophoretic activity in neonatal rat islets following islet-activating protein.
    Dunlop ME; Larkins RG
    Biochem Biophys Res Commun; 1983 Apr; 112(2):684-92. PubMed ID: 6342618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet-activating protein (IAP) reduces bethanechol-stimulated release of pancreatic polypeptide in the dog.
    Hanafusa T; Toyoshima H; Nonaka K; Tarui S
    Endocrinol Jpn; 1982 Jun; 29(3):357-61. PubMed ID: 6756897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective impairment of pancreatic A cell suppression by glucose during acute alloxan-induced insulinopenia: in vitro study on isolated perfused rat pancreas.
    Filipponi P; Gregorio F; Cristallini S; Ferrandina C; Nicoletti I; Santeusanio F
    Endocrinology; 1986 Jul; 119(1):408-15. PubMed ID: 3522213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of islet-activating protein (IAP) of pertussis toxin on the spontaneous diabetic syndrome in the rat.
    Bergada I; Colle E; Seemayer TA
    Diabetes Res; 1989 Jun; 11(2):85-91. PubMed ID: 2695283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological properties of islets-activating protein (IAP) purified from the culture medium of Bordetella pertussis.
    Yajima M; Hosoda K; Kanbayashi Y; Nakamura T; Takahashi I; Ui M
    J Biochem; 1978 Jan; 83(1):305-12. PubMed ID: 203575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of islet-activating protein (IAP) on long-term functional maintenance of cultured islets.
    Taniguchi H; Tsutou A; Ejiri K; Tamagawa M; Ishihara K; Baba S
    Kobe J Med Sci; 1982 Dec; 28(5-6):211-6. PubMed ID: 6763105
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of in vivo pretreatment of rats with a new protein purified from Bordetella pertussis on in vitro secretion of insulin: role of calcium.
    Katada T; Ui M
    Endocrinology; 1979 Jun; 104(6):1822-7. PubMed ID: 376293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastoparan-induced hormone release from rat pancreatic islets.
    Komatsu M; Aizawa T; Yokokawa N; Sato Y; Okada N; Takasu N; Yamada T
    Endocrinology; 1992 Jan; 130(1):221-8. PubMed ID: 1727698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of islet activating protein on glucose tolerance, insulin secretion and insulin responsiveness in the NZO mouse.
    Re CA; Veroni MC; Larkins RG
    Diabetologia; 1984 Apr; 26(4):304-9. PubMed ID: 6376239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.